Literature DB >> 29663524

Early echocardiography does not predict subsequent treatment of symptomatic patent ductus arteriosus in extremely preterm infants.

Sujith S Pereira1,2, Stephen T Kempley1,2, Divyen K Shah1,2, Joan K Morris3, Ajay K Sinha1,2.   

Abstract

AIM: To determine whether early echocardiographic ductal parameters identified infants who subsequently received medical or surgical treatment of the patent ductus arteriosus (PDA).
METHODS: Infants <29 weeks had PDA size in 2D and colour, flow velocity and patterns obtained on days 1 and 3. Infants were followed up to identify those subsequently receiving treatment for symptomatic PDA by clinicians who were unaware of scan results. Receiver operator characteristics curves and logistic regression were performed.
RESULTS: Sixty infants were studied. Mean (SD) gestation and birthweight were 25.8 (1.5) weeks and 817 (190) grams, respectively. Twenty-four (40%) infants received medical treatment, and nine (15%) infants received surgical ligation of PDA at a median age of 12 and 37 days, respectively. PDA size on days 1 and 3, change in ductal size between days 1 and 3, flow pattern/velocity did not predict whether infants subsequently received medical or surgical management of PDA. Using logistic regression, gestation (p = 0.006) was the only factor that predicted whether infants would subsequently receive medical or surgical treatment for PDA in this cohort.
CONCLUSION: Echocardiographic ductal parameters on day 1 or 3 did not identify infants who received PDA treatment. Gestation was the most powerful predictor for receiving medical or surgical treatment of PDA. ©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Echocardiography; PDA treatment; Patent ductus arteriosus; Preterm infant

Mesh:

Year:  2018        PMID: 29663524     DOI: 10.1111/apa.14361

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  A Matched Case Control Study of Surgically and Non-surgically Treated Patent Ductus Arteriosus in Extremely Pre-term Infants.

Authors:  Karl Wilhelm Olsson; Sawin Youssef; Mattias Kjellberg; Renske Raaijmakers; Richard Sindelar
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

2.  Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.

Authors:  Anna Gudmundsdottir; Marco Bartocci; Oda Picard; Joanna Ekström; Alexander Chakhunashvili; Kajsa Bohlin; Caroline Attner; Gordana Printz; Mathias Karlsson; Lilly-Ann Mohlkert; Jonna Karlén; Cecilia Pegelow Halvorsen; Anna-Karin Edstedt Bonamy
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 3.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.